Moody’s downgrades Senegal to Caa1 amid rising debt concerns
Shattuck Labs, Inc. (NASDAQ:STTK) reported the results of its 2025 Annual Meeting of Stockholders held Thursday. According to a press release statement based on the company’s SEC filing, all director nominees were elected and the proposal to ratify the independent auditor was approved. The company, currently trading at $0.79 per share, maintains a strong liquidity position with a current ratio of 9.08x, though InvestingPro analysis indicates the company is rapidly consuming its cash reserves.
As of the record date of May 14, 2025, there were 47,903,215 shares of common stock eligible to vote. The meeting included two main proposals. With a market capitalization of approximately $38 million, InvestingPro data suggests the stock is currently undervalued, though investors should note the company’s significant volatility and challenging financial metrics.
For the election of Class II directors, Neil Gibson, Ph.D., received 29,632,587 votes for and 2,367,630 votes withheld. George Golumbeski, Ph.D., received 30,303,315 votes for and 1,696,902 votes withheld. Kate Sasser, Ph.D., received 30,351,437 votes for and 1,648,780 votes withheld. Each nominee was elected to the board. There were 9,026,584 broker non-votes on each of these elections.
The second proposal, to ratify KPMG LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2025, was approved. The vote totals were 41,016,269 for, 5,482 against, and 5,050 abstentions, with no broker non-votes reported for this item.
Shattuck Labs, based in Austin, Texas, is incorporated in Delaware and its common stock is listed on the Nasdaq Global Select Market. The company is classified under pharmaceutical preparations.
All information in this article is based on a press release statement and the company’s recent SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.